HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

International Cancer Research Conference

March 24-26, 2025 | Singapore

March 24 -26, 2025 | Singapore

Cancer Research 2025

Speaker at International Cancer Research Conference 2025 - Jianhua Luo
Keynote Presentation (In-Person)
Jianhua Luo, University of Pittsburgh, United States

Will be Updated Soon...

Speaker at International Cancer Research Conference 2025 - Pietro Salvatori
Keynote Presentation (In-Person)
Pietro Salvatori, Independent H&N Surgeon, Italy

Treatment goals for Head & Neck cancers can be indicated as: 1) Eradication of the tumor (ablative surgery or XRT, combinations), 2) Restoration of the anatomy (reconstructive surgery), 3) Rehabilitation of the function. Of course, the main goals are to increase survi [....] » Read More

Speaker at International Cancer Research Conference 2025 - Marika Crohns
Keynote Presentation (In-Person)
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates

Will be Updated Soon...

Speaker at International Cancer Research Conference 2025 - Ibrahim El Bayoumy
Oral Presentation (In-Person)
Ibrahim El Bayoumy, Consultant of public health-Ministry of Health, Kuwait

Background Colorectal cancer accounts for approximately 10% of all annually diagnosed cancers and cancer-related deaths worldwide.1 It is the second most common cancer diagnosed in women and third most in men. In women, incidence and mortality are approximately 25% lower than in [....] » Read More

Speaker at International Cancer Research Conference 2025 - Changjiang Yang
Oral Presentation (In-Person)
Changjiang Yang, Peking University People's Hospital, China

Recent research has linked Importin7 to cancer aggressiveness and a dismal prognosis, but its function in colorectal cancer (CRC) is unclear. This study aimed to elucidate the clinical relevance, biological function, and potential molecular mechanisms of IPO7 in CRC. Our results [....] » Read More

Speaker at International Cancer Research Conference 2025 - Jian Li
Oral Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Conventional neoadjuvant chemotherapy offers limited benefit for patients with resectable non-small-cell lung cancer (NSCLC). Recently, neoadjuvant chemoimmunotherapy (NCIT) has transformed perioperative management of NSCLC by priming systemic anti-tumor immunity before surgery, [....] » Read More

Speaker at International Cancer Research Conference 2025 - Baolong Li
Oral Presentation (In-Person)
Baolong Li, Fujian Medical University Union Hospital, China

Background: The 8th edition of the AJCC staging system for gastric cancer introduced the ypTNM staging. However, in clinical practice, we have observed that the accuracy of its prognostic assessment remains controversial. This study aims to develop a more precise and refined ypTN [....] » Read More

Speaker at International Cancer Research Conference 2025 - Beibei Xie
Oral Presentation (In-Person)
Beibei Xie, University of Macau, China

Although various ferroptosis inducers including magnetic nanoparticles (Fe3O4) and iron-organic frameworks have been applied in cancer treatment, the mild immunogenicity, low targeting efficiency to the tumor, and poor tissue penetration have limited the therapeutic efficacy. Her [....] » Read More

Speaker at International Cancer Research Conference 2025 - Vinoth Kumar Lakshmanan
Oral Presentation (In-Person)
Vinoth Kumar Lakshmanan, Sri Ramachandra Institute of Higher Education and Research, India

Prostate cancer (PC) is the most common cancer affecting men and the third leading cause of cancer death. Despite recent advances in detection and localized curative treatment for prostate cancer, 23-40% of those patients will go on to develop metastatic disease. Castration-Resis [....] » Read More

Speaker at International Cancer Research Conference 2025 - Namrata P Awasthi
Oral Presentation (In-Person)
Namrata P Awasthi, Dr. Ram Manohar Lohia Institute of Medical Sciences, India

Background: The lecture will introduce the audience to commonly utilized techniques for Cytology of malignant fluids including cytospin, cell block and immunohistochemistry. The advantages and limitations of the techniques will be discussed. Further, basics of flow cytometry (FCM [....] » Read More

Speaker at International Cancer Research Conference 2025 - Shivam Singh
Oral Presentation (In-Person)
Shivam Singh, All India Institute of Medical Sciences, India

Background: The incidence of breast cancer has increased while the mortality rate has continued to remain high. Effective treatment of this disease is the key to survival. Therefore, this study is a necessity in continuing research into new effective treatments. According to anci [....] » Read More

Speaker at International Cancer Research Conference 2025 - Phyu Ou Maung
Oral Presentation (In-Person)
Phyu Ou Maung, University of Dental Medicine, Myanmar

Background: Oral squamous cell carcinoma (OSCC) has become a major oncologic problem. Survivin overexpression in OSCC could be associated with increased aggressiveness, poor response to chemotherapy and prediction of patient survival. This study was conducted to analyze the mRNA [....] » Read More

Speaker at International Cancer Research Conference 2025 - Isah Musa Fakai
Oral Presentation (In-Person)
Isah Musa Fakai, Kebbi State University of Science and Technology, Nigeria

The epidermal growth factor receptor (EGFR) pathway is an important signaling cascade currently investigated for its involvement in cancer therapy. In this study, chalepin isolated from Ruta angustifolia was evaluated for its down regulatory activity on the EGFR signaling cascade [....] » Read More

Speaker at International Cancer Research Conference 2025 - Ahmed Al Awadh
Poster Presentation (In-Person)
Ahmed Al Awadh, Najran University, Saudi Arabia

Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. This study aimed to evaluate the effects of euxanthone on the proliferation and migration of HCC cell lines and elucidate the underlying molecular mechanisms. Methods: HCC cell [....] » Read More

Speaker at International Cancer Research Conference 2025 - Niu Yuchun
Poster Presentation (In-Person)
Niu Yuchun, Oncology Hospital of the First People's Hospital of Foshan, China

Understanding the Role of Super-enhancer MYCNOS-SE in Chemoresistance of Small Cell Lung Cancer. Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid progression and a high propensity for chemotherapy resistance. This presentation will discuss [....] » Read More

Speaker at International Cancer Research Conference 2025 - Chanchan Gao
Poster Presentation (In-Person)
Chanchan Gao, Southeast University Zhongda Hospital, China

Objective: This study aimed to investigate the role of RGS2 in immune regulation and its impact on the efficacy of PD-1/PD-L1 blockade therapy in lung cancer (LC), as well as to explore the regulatory relationship between RGS2 and BATF2 in modulating T cell exhaustion and tumor i [....] » Read More

Speaker at International Cancer Research Conference 2025 - Yu Yang
Poster Presentation (In-Person)
Yu Yang, Beijing Friendship Hospital, Capital Medical University, China

Introduction: Bladder cancer is one of the top 10 most common cancers. Although radical cystectomy (RC) is the standard treatment, it significantly compromises quality of life. This study explores percutaneous ablation as a main treatment combined with multimodal therapy as [....] » Read More

Speaker at International Cancer Research Conference 2025 - Jian Li
Poster Presentation (In-Person)
Jian Li, Shanghai Jiaotong University, China

Neoadjuvant immunotherapy with anti-programmed death-1 (neo-antiPD1) has revolutionized perioperative treatment for improving the overall survival (OS) of patients with early-stage lung cancer. Despite its transformative impact, neo-antiPD1 provides limited benefit to nearly 50% [....] » Read More

Speaker at International Cancer Research Conference 2025 - Hefdhallah Al-Aizari
Poster Presentation (In-Person)
Hefdhallah Al-Aizari, Ibn Tofail University, Morocco

Participatory and collaborative communication plays a crucial role in territorial governance to find innovative solutions for the proper functioning of public service. This study examines the importance of participatory and collaborative communication in good territorial governan [....] » Read More

Speaker at International Cancer Research Conference 2025 - Davoud Shojaeizadeh
Poster Presentation (In-Person)
Davoud Shojaeizadeh, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Esophageal cancer is one of the most widespread disease in Golestan Province , Iran. To identify risk factors a lot of research has been done. Because health workers have successful experiences of health education. The purpose of this study is to use social marketing to influence [....] » Read More

Speaker at International Cancer Research Conference 2025 - Atif A Ahmed
Keynote Presentation (Virtual)
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States

RNA binding proteins (RBPs) are regulators of RNA metabolism and influence protein expression in various physiologic and pathologic conditions through regulation of RNA splicing, stability and translation. Several studies have demonstrated that RBPs play a role in cancer developm [....] » Read More

Speaker at International Cancer Research Conference 2025 - Rajvir Dahiya
Keynote Presentation (Virtual)
Rajvir Dahiya, University of California San Francisco, United States

Background: Current screening methods, have limitations in the diagnosis and prognosis of prostate cancer. This study examined whether mRNA-genomic biomarkers can improve screening and monitoring of prostate cancer. Methods: We identified a panel of 25 prostate cancer-related [....] » Read More

Speaker at International Cancer Research Conference 2025 - Michael Thompson
Keynote Presentation (Virtual)
Michael Thompson, University of Toronto, Canada

Biosensor technology represents an attractive strategy for the detection and monitoring of biomarkers for disease states within the context of precision medicine. This approach offers the possibility for biomarker assay via incorporation into an automated robotic system to proces [....] » Read More

Speaker at International Cancer Research Conference 2025 - Patricia Tai
Keynote Presentation (Virtual)
Patricia Tai, UpToDate, Canada

About 2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime and 1 in 4 die of it. I would discuss interesting updates of advances in cancer research. Biomarker assays have become routine for some cancers. Circulating tumor cells/cell-free deoxyribonucleic [....] » Read More

Speaker at International Cancer Research Conference 2025 - Bene Ekine-Afolabi
Keynote Presentation (Virtual)
Bene Ekine-Afolabi, University of East London, United Kingdom

Drug metabolism is crucial in any functioning of a drug, particularly in drugs for cancer treatment. Several drugs do not function in human body in their original state unless metabolised to its required functioning metabolite to affect its target organ/site or tissue. Drug metab [....] » Read More

Speaker at International Cancer Research Conference 2025 - Sergio Marchini
Keynote Presentation (Virtual)
Sergio Marchini, Humanitas Clinical Institute IRCCS, Italy

Will be Updated Soon...

Speaker at International Cancer Research Conference 2025 - Kaushala Prasad Mishra
Keynote Presentation (Virtual)
Kaushala Prasad Mishra, Asian Association for Radiation Research (AARR), India

Will be Updated Soon...

Speaker at International Cancer Research Conference 2025 - Özlem Terzi
Oral Presentation (Virtual)
Özlem Terzi, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Turkey

Febrile neutropenia (FEN) is the most common life-threatening complication of childhood cancer. Early initiation of broad-spectrum intravenous antibiotics to patients has reduced the mortality of FEN below 5%. Studies have reported viral infections to constitute 35 to 55% of FEN [....] » Read More

Speaker at International Cancer Research Conference 2025 - Andrea González Báez
Oral Presentation (Virtual)
Andrea González Báez, Autonomous University of Nuevo Leon, Mexico

Cancer is a complex pathology of great relevance for public health due to its high mortality and morbidity. Specifically breast cancer, is one of the main causes of death in women worldwide, demonstrating that its incidence has been exponentially uprising. The multifactorial natu [....] » Read More

Speaker at International Cancer Research Conference 2025 - Liling Jiang
Oral Presentation (Virtual)
Liling Jiang, Shapingba District People's Hospital of Chongqing, China

All studies were performed on a 3 T whole-body MRI system (MAGNETOM Prisma, Siemens Healthineers, Erlangen, Germany) using a 16-channel surface coil (Zhongzhi Medical, Jiangsu). Firstly, we evaluated the thyroid nodule image quality between two diffusion weighted imaging (DWI) te [....] » Read More

Speaker at International Cancer Research Conference 2025 - Qian Zhang
Oral Presentation (Virtual)
Qian Zhang, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, China

Autophagy exerts a vital role in lung squamous cell carcinoma (LUSC) progression. Ubiquitin Specific Peptidase 31 (USP31) has recently been found to be involved in the development of a variety of cancers. However, whether USP31 modulates autophagy in LUSC remains uncovered. This [....] » Read More

Speaker at International Cancer Research Conference 2025 - Zheng Wang
Oral Presentation (Virtual)
Zheng Wang, Shanghai Jiao Tong University School of Medicine, China

My topic focus on precision medicine and translational research of breast cancer, including three parts: 1. Homologous recombination repair deficiency in breast cancer; 2. Clinical patterns and predictive models of cancer metastasis; 3. Tumor immunity and the immune microenvironm [....] » Read More

Speaker at International Cancer Research Conference 2025 - Shaoguang Feng
Oral Presentation (Virtual)
Shaoguang Feng, Hangzhou Children's Hospital, China

Purpose: Desmoplastic Small Round Cell Tumor (DSRCT) in children is extremely rare and aggressive. We aimed to conduct a population-based cohort study to predict overall survival (OS) in pediatric patients with DSRCT. Methods: Using the Surveillance, Epidemiology and [....] » Read More

Speaker at International Cancer Research Conference 2025 - K R Muralidhar
Oral Presentation (Virtual)
K R Muralidhar, Karkinos Healthcare, India

The discussion will be on optimum utilization of AI and genomics in delivering personalized treatments inRadiationOncology for better treatment outcome. Artificial Intellignce , Machine learing and Deep learning will bediscussedand the future of artificial intelligence in radiati [....] » Read More

Speaker at International Cancer Research Conference 2025 - Saumya Pandey
Oral Presentation (Virtual)
Saumya Pandey, Indira IVF Hospital, India

Objective: Dissecting the cellular/molecular/genetic regulatory biochemical signaling networks: Autophagy/Toll-like Receptors/Wnt-Frizzled in inflammatory “gastrohepatic disease-web” primarily hepatocellular/colorectal/cholangiocarcinomas is essential for diminishing [....] » Read More

Speaker at International Cancer Research Conference 2025 -  Luiza Simonyan
Oral Presentation (Virtual)
Luiza Simonyan, L. A. Orbeli Institute of Physiology NAS RA, Armenia

Modern medical methods of treatment allow in some cases to prevent the development of pathological processes in the human body. It is known that the effectiveness of such therapeutic effects is largely determined by the possibility of diagnosing the disease at the initial stages [....] » Read More

Speaker at International Cancer Research Conference 2025 - Alireza Bahramian
Oral Presentation (Virtual)
Alireza Bahramian, University of Tehran, Iran (Islamic Republic of)

This study introduces a novel thermodynamic marker for cancer diagnosis, revealing a fundamental interrelationship between membrane tension, the aspect ratio of cells during late anaphase, and spindle angle. Central to this discovery is the identification of Inter-Cyto-Tension (I [....] » Read More

Speaker at International Cancer Research Conference 2025 - Nayab Mustansar
Oral Presentation (Virtual)
Nayab Mustansar, Fc Teaching Hospital Peshawar, Pakistan

Neuroendocrine tumours (NETs) of the gallbladder are rare and represent a challenging clinical scenario due to their aggressive nature and late presentation. We report a case of a 60-year-old female diagnosed with a stage 4B neuroendocrine tumour of the gallbladder. This case und [....] » Read More

Speaker at International Cancer Research Conference 2025 - Timothy Makumbi Kabanda
Oral Presentation (Virtual)
Timothy Makumbi Kabanda, Makerere University Kampala, Uganda

Introduction: Worldwide, breast cancer comprises one third of all cancers affecting women. Disparities are exhibited by this condition in tumor biology and clinical behavior. No single cure has been identified as a result of these characteristics. Scientists all around the globe, [....] » Read More

Speaker at International Cancer Research Conference 2025 - Maurice T. Agonnoude
Oral Presentation (Virtual)
Maurice T. Agonnoude, Parakou University, Benin

Introduction: The integration of breast cancer screening into daily clinical care leads to an early diagnosis and reduces its mortality. However, many women are reluctant and do not get tested. Objective To study the factors associated with the practice of breast cancer scre [....] » Read More

Speaker at International Cancer Research Conference 2025 - Dago Dougba Noel
Oral Presentation (Virtual)
Dago Dougba Noel, Peleforo Gon Coulibaly University, Cote d'Ivoire

Cancers are genetic and epigenetic diseases in which cells divide and grow in uncontrolled ways due to mutations or molecular alterations. Gene fusion phenomena is recurrent in cancer cells. One of the most common cancers is breast cancer, representing worldwide public health con [....] » Read More

Speaker at International Cancer Research Conference 2025 - Hao Sun
Poster Presentation (Virtual)
Hao Sun, Chongqing University Cancer Hospital, China

Background: We developed the laparoscopic and endoscopic cooperative surgery (LECS) technique, which combines non-exposed wall-inversion surgery (NEWS) and sentinel node navigation surgery (SNNS) to treat early gastric cancer (EGC). It is a technique which preserves organ functio [....] » Read More

Speaker at International Cancer Research Conference 2025 - Shuaiqi Wang
Poster Presentation (Virtual)
Shuaiqi Wang, Chongqing University Cancer Hospital, China

Background: We developed the laparoscopic and endoscopic cooperative surgery (LECS) technique, which combines non-exposed wall-inversion surgery (NEWS) and sentinel node navigation surgery (SNNS) to treat early gastric cancer (EGC). It is a technique which preserves organ functio [....] » Read More

Will be updated soon......
Watsapp